SCHEMBL19079934

SCHEMBL19079934

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5c(c4)c4ccccc4c4c5oc5c6ccccc6c6ccccc6c54)cc3)c3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 6/20 0.40
▸ PLA2G4A P47712 6/20 0.40
▸ CDK1 P06493 1/20 0.36
▸ CCNB1 P14635 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ CDK5 Q00535 1/20 0.36
▸ CDK5R1 Q15078 1/20 0.36
▸ ESR1 P03372 2/20 0.36
▸ ESR2 Q92731 2/20 0.36
▸ PLA2G10 O15496 1/20 0.35
▸ CA1 P00915 3/20 0.34
▸ CA2 P00918 3/20 0.34
▸ ERAP1 Q9NZ08 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.33
▸ CYP3A4 P08684 3/20 0.33
▸ CYP1B1 Q16678 3/20 0.33
▸ TP53 P04637 2/20 0.33
▸ ABCB1 P08183 2/20 0.33
▸ CYP19A1 P11511 2/20 0.33
▸ HPGD P15428 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080044 0.91 ESR1 (0.38) PLA2G2APLA2G4ACDK1CCNB1GSK3B
SCHEMBL19079946 0.91 PLA2G2A (0.40) PLA2G2APLA2G4ACDK1CCNB1GSK3B
SCHEMBL22260544 0.89 CYP1A1 (0.45) CYP3A4CYP1B1TP53ABCB1CYP19A1
SCHEMBL17931941 0.88 PLA2G2A (0.43) PLA2G2APLA2G4ACDK1CCNB1GSK3B
SCHEMBL19080032 0.88 CDK1 (0.33) PLA2G2APLA2G4ACDK1CCNB1GSK3B
SCHEMBL19079933 0.87 CYP1A1 (0.44) CYP3A4CYP1B1TP53ABCB1CYP19A1
SCHEMBL17577237 0.87 PLA2G2A (0.36) PLA2G2APLA2G4ACDK1CCNB1GSK3B
SCHEMBL22155574 0.87 PLA2G2A (0.36) PLA2G2APLA2G4ACDK1CCNB1GSK3B
SCHEMBL19079998 0.87 CYP1A1 (0.41) ESR1ESR2CA1CA2GPR84
SCHEMBL17577243 0.87 PLA2G2A (0.36) PLA2G2APLA2G4ACDK1CCNB1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 — — US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 — — US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 PLA2G2A 4537/4885PLA2G4A 4462/4885CDK1 15/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 PLA2G2A 4537/4885PLA2G4A 4462/4885CDK1 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback